Femara and dyspnoea Patient Reports February 10, 2012

Femara Side Effects Report #5261861-X
Femara side effect was reported by a Consumer or non-health professional from BRAZIL on Feb 23, 2007. Female patient, weighting 220.5 lb, was diagnosed with breast mass, blood cholesterol increased, hyperglycaemia, labyrinthitis and was treated with Femara. After drug was administered, patient experienced the following side effects: abnormal sleep-related event, dyspnoea, fatigue, feeling hot, hyperhidrosis, weight increased. Femara dosage: unknown. During the same period patient was treated with DAFLON, SIMVASTATIN, METFORMINA, DIAZEPAM, STUGERON, PIRACETAM. Patient recovered.

Femara Side Effects Report #5295930-5
Femara side effect was reported by a Consumer or non-health professional from BRAZIL on Apr 02, 2007. Female patient, weighting 220.5 lb, was diagnosed with breast mass, blood cholesterol increased, hyperglycaemia, labyrinthitis and was treated with Femara. After drug was administered, patient experienced the following side effects: abnormal sleep-related event, blood thyroid stimulating hormone increased, cataract

, conjunctivitis, dyspnoea, fatigue, feeling hot, hyperhidrosis. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DAFLON, SIMVASTATIN, METFORMINA, DIAZEPAM, STUGERON, PIRACETAM. Patient recovered.

Femara Side Effects Report #5385396-9
Femara side effect was reported by a Consumer or non-health professional from BRAZIL on June 29, 2007. Female patient, weighting 233.7 lb, was diagnosed with breast mass, blood cholesterol increased, hyperglycaemia, labyrinthitis and was treated with Femara. After drug was administered, patient experienced the following side effects: abnormal sleep-related event, blood thyroid stimulating hormone increased, burning sensation, cataract

, conjunctivitis, dyspnoea, fatigue, feeling hot. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DAFLON, SIMVASTATIN, METFORMINA, DIAZEPAM, STUGERON, PIRACETAM. Patient recovered.

Femara Side Effects Report #5385637-8
Femara side effect was reported by a Consumer or non-health professional from BRAZIL on June 29, 2007. Female patient, weighting 233.7 lb, was diagnosed with breast mass, blood cholesterol increased, hyperglycaemia, labyrinthitis and was treated with Femara. After drug was administered, patient experienced the following side effects: abnormal sleep-related event, blood thyroid stimulating hormone increased, burning sensation, cataract

, conjunctivitis, dyspnoea, fatigue, feeling hot. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DAFLON, SIMVASTATIN, METFORMINA, DIAZEPAM, STUGERON, PIRACETAM. Patient recovered.

Femara Side Effects Report #5389465-9
Femara side effect was reported by a Consumer or non-health professional from BRAZIL on July 11, 2007. Female patient, weighting 233.7 lb, was diagnosed with breast mass, blood cholesterol increased, hyperglycaemia, labyrinthitis and was treated with Femara. After drug was administered, patient experienced the following side effects: abnormal sleep-related event, blood thyroid stimulating hormone increased, burning sensation, cataract

, conjunctivitis, dyspnoea, fatigue, feeling hot. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DAFLON, SIMVASTATIN, METFORMINA, DIAZEPAM, STUGERON, PIRACETAM. Patient recovered.

Femara Side Effects Report #5506591-1
Femara side effect was reported by a Consumer or non-health professional from BRAZIL on Oct 29, 2007. Female patient, weighting 233.7 lb, was diagnosed with breast mass, blood cholesterol increased, hyperglycaemia, labyrinthitis and was treated with Femara. After drug was administered, patient experienced the following side effects: abnormal sleep-related event, blood thyroid stimulating hormone increased, burning sensation, cataract

, conjunctivitis, dyspnoea, fatigue, feeling hot. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DAFLON, SIMVASTATIN, METFORMINA, DIAZEPAM, STUGERON, PIRACETAM. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4638041-1
Femara side effect was reported by a Consumer or non-health professional from on Apr 04, 2005. Female patient, 52 years of age, was diagnosed with breast cancer stage iv and was treated with Femara. After drug was administered, patient experienced the following side effects: agitation, arrhythmia

, blood thyroid stimulating hormone increased, cough, dyspnoea, heart rate increased, insomnia, malignant neoplasm progression, platelet count decreased. Femara dosage: unknown. During the same period patient was treated with ZOMETA. Patient recovered.

Femara Side Effects Report #5787773-0
Femara side effect was reported by a Physician from JAPAN on June 11, 2008. Female patient was diagnosed with breast cancer recurrent, metastases to bone and was treated with Femara. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea, echography abnormal, palpitations, stridor. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5802084-2
Femara side effect was reported by a Physician from JAPAN on June 25, 2008. Female patient, weighting 134.5 lb, was diagnosed with breast cancer recurrent, metastases to bone, chronic hepatitis, gastritis, constipation

and was treated with Femara. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood cholesterol increased, blood glucose increased, blood lactate dehydrogenase increased, cardiac failure congestive, dyspnoea, echocardiogram abnormal, eosinophil count decreased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, BARACLUDE, VOLTAREN, OMEPRAZOLE, URSO, MAGMITT KENEI. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5215568-5
Femara side effect was reported by a Physician from UNITED KINGDOM on Jan 12, 2007. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, life support, lung disorder, malignant neoplasm progression, oedema peripheral, pleural effusion, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ADVAIR DISKUS. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5234236-7
Femara side effect was reported by a Physician from UNITED KINGDOM on Jan 26, 2007. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, life support, lung disorder, malignant neoplasm progression, oedema peripheral, pleural effusion, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ADVAIR DISKUS, FLUTICASONE W. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5234243-4
Femara side effect was reported by a Physician from UNITED KINGDOM on Jan 26, 2007. Female patient, 59 years of age, was diagnosed with breast cancer metastatic and was treated with Femara. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, life support, lung disorder, malignant neoplasm progression, oedema peripheral, pleural effusion, wheezing. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ADVAIR DISKUS, FLUTICASONE W. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #4862514-X
Femara side effect was reported by a Physician from GERMANY on Nov 14, 2005. Female patient, 64 years of age, weighting 114.6 lb, was diagnosed with breast cancer female and was treated with Femara. After drug was administered, patient experienced the following side effects: alveolitis, dyspnoea. Femara dosage: 2.5 MG, QD. During the same period patient was treated with URBASON. Patient recovered.

Femara Side Effects Report #5635988-4
Femara side effect was reported by a Physician from GERMANY on Feb 19, 2008. Female patient, 80 years of age, weighting 156.5 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, endotracheal intubation, increased bronchial secretion, mechanical ventilation, respiratory distress. Femara dosage: 2.5 MG. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5638982-2
Femara side effect was reported by a Physician from GERMANY on Feb 19, 2008. Female patient, 80 years of age, weighting 156.5 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, endotracheal intubation, increased bronchial secretion, mechanical ventilation, respiratory distress. Femara dosage: 2.5 MG. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5644277-3
Femara side effect was reported by a Physician from ESTONIA on Feb 21, 2008. Female patient, 80 years of age, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, c-reactive protein increased, cough, dyspnoea, eosinophilic pneumonia, leukocytosis, myalgia, thrombocythaemia. Femara dosage: unknown. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5729227-3
Femara side effect was reported by a Physician from GERMANY on Apr 30, 2008. Female patient, 80 years of age, weighting 156.5 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, endotracheal intubation, increased bronchial secretion, mechanical ventilation, respiratory distress. Femara dosage: 2.5 MG. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5742966-3
Femara side effect was reported by a Physician from GERMANY on May 15, 2008. Female patient, 80 years of age, weighting 156.5 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, increased bronchial secretion, mechanical ventilation, respiratory distress. Femara dosage: 2.5 MG. During the same period patient was treated with ZOLEDRONIC ACID. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5195508-8
Femara side effect was reported by a Physician from BELGIUM on Dec 22, 2006. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis, rales. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5268170-3
Femara side effect was reported by a Physician from UNITED STATES on Mar 06, 2007. Female patient, 77 years of age, was diagnosed with breast cancer

, hypertension, incontinence and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, tachypnoea. Femara dosage: 2.5 MG, QD. During the same period patient was treated with NORVASC, DITROPAN. Patient recovered.

Femara Side Effects Report #5169734-8
Femara side effect was reported by a Physician from BELGIUM on Nov 30, 2006. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5181087-8
Femara side effect was reported by a Physician from BELGIUM on Nov 30, 2006. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis, rales. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5447180-7
Femara side effect was reported by a Physician from BELGIUM on Sept 10, 2007. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis, rales. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5532027-0
Femara side effect was reported by a Physician from BELGIUM on Nov 23, 2007. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis, rales. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5567834-1
Femara side effect was reported by a Physician from BELGIUM on Dec 11, 2007. Female patient, 77 years of age, weighting 119.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pneumonitis, rales. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #4964279-X
Femara side effect was reported by a Consumer or non-health professional from CANADA on Mar 24, 2006. Female patient, 74 years of age, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dysphagia, dyspnoea, oesophageal disorder. Femara dosage: 2.5 MG, QD. During the same period patient was treated with CARBOCAL D, AVANDIA, ALLOPURINOL, AMLODIPINE BESYLATE, LIPITOR. Patient recovered.

Femara Side Effects Report #4836271-7
Femara side effect was reported by a Physician from GERMANY on Nov 14, 2005. Female patient, 64 years of age, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: alveolitis, dyspnoea. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5403631-5
Femara side effect was reported by a Consumer or non-health professional from JAPAN on July 26, 2007. Female patient, 61 years of age, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, pleural effusion, respiratory failure. Femara dosage: 2.5 MG/DAY. Patient died on 05/16/2007.

Femara Side Effects Report #4788112-4
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 05, 2004. Female patient, 58 years of age, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: aspiration pleural cavity, breast cancer

, disease progression, dyspnoea, lung neoplasm, malignant pleural effusion, pulmonary function test decreased. Femara dosage: 2.5 MG, QD. Patient recovered.

Femara Side Effects Report #5691376-6
Femara side effect was reported by a Consumer or non-health professional from GERMANY on Mar 20, 2008. Female patient, 57 years of age, weighting 130.1 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: arteriosclerosis, ataxia

, carpal tunnel syndrome

, diplopia, dizziness

, dyspnoea, electrocardiogram ambulatory abnormal, eyelid ptosis, facial paresis. Femara dosage: 2.5 MG, QD. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #5083654-9
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, 52 years of age, weighting 234.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: anaphylactic reaction, dyspnoea, loss of consciousness, pharyngeal oedema, rash

, syncope, urticaria. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5105399-9
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on May 25, 2006. Female patient, 52 years of age, weighting 234.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: anaphylactic reaction, dyspnoea, loss of consciousness, pharyngeal oedema, rash

, syncope, urticaria. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5970961-8
Femara side effect was reported by a Pharmacist from UNITED STATES on Nov 19, 2008. Female patient, 52 years of age, weighting 152.0 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: cough, dyspnoea, pneumonitis. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZETIA, TRICOR, FLEXERIL, DARVOCET, ZANTAC, PRILOSEC, CALCIUM. Patient recovered.

Femara Side Effects Report #5040445-2
Femara side effect was reported by a Consumer or non-health professional from KAZAKHSTAN on June 21, 2006. Female patient, 49 years of age, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: back pain

, dyspnoea, myalgia, pain in extremity, pyrexia. Femara dosage: unknown. Patient recovered.

Femara Side Effects Report #5152839-5
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 21, 2006. Female patient was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: dyspnoea, hypertension. Femara dosage: 2.5 MG, QD, ORAL. Patient recovered.

Femara Side Effects Report #5160687-5
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 11, 2006. Female patient was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: carpal tunnel syndrome

, dizziness

, dyspnoea, hot flush, myalgia, tremor. Femara dosage: 2. 5 MG, QD, ORAL. Patient recovered.

Femara Side Effects Report #5810924-6
Femara side effect was reported by a Physician from JAPAN on July 07, 2008. Female patient, weighting 110.2 lb, was diagnosed with breast cancer

, breast cancer recurrent and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral infarction, dyslalia, dyspnoea, gamma-glutamyltransferase increased, metastases to lung, pericardial drainage. Femara dosage: 2.5 MG/DAY. During the same period patient was treated with FARESTON, LASIX, TOREMIFENE. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5836483-X
Femara side effect was reported by a Physician from JAPAN on Aug 01, 2008. Female patient, weighting 110.2 lb, was diagnosed with breast cancer

, breast cancer recurrent and was treated with Femara. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebral infarction, dyslalia, dyspnoea, gamma-glutamyltransferase increased, metastases to lung, pericardial drainage. Femara dosage: 2.5 MG/DAY. During the same period patient was treated with FARESTON, LASIX, TOREMIFENE. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #5947523-1
Femara side effect was reported by a Health Professional from FRANCE on Oct 31, 2008. Female patient, weighting 123.5 lb, was diagnosed with breast cancer

, depression

and was treated with Femara. After drug was administered, patient experienced the following side effects: asthenia, bundle branch block left, cardiac failure, congestive cardiomyopathy, dyspnoea, ejection fraction decreased, left atrial dilatation, mitral valve incompetence, orthopnoea. Femara dosage: 2.5 MG, QD. During the same period patient was treated with DEROXAT. Patient was hospitalized and became disabled. Patient recovered.

Femara Side Effects Report #6046606-8
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 14, 2009. Female patient, weighting 152.0 lb, was diagnosed with breast cancer

, dyslipidaemia and was treated with Femara. After drug was administered, patient experienced the following side effects: cough, dyspnoea, pneumonitis. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZETIA, TRICOR, FLEXERIL, DARVOCET, ZANTAC, PRILOSEC, CALCIUM. Patient recovered.

Femara Side Effects Report #6103731-0
Femara side effect was reported by a Physician from JAPAN on Feb 25, 2009. Female patient, weighting 154.3 lb, was diagnosed with breast cancer

and was treated with Femara. After drug was administered, patient experienced the following side effects: chest x-ray abnormal, dyspnoea, interstitial lung disease, lymphangiosis carcinomatosa, oxygen saturation decreased. Femara dosage: 2.5 MG, QD. During the same period patient was treated with NAVELBINE. Patient was hospitalized. Patient recovered.

Femara Side Effects Report #6123599-6
Femara side effect was reported by a Physician from JAPAN on Mar 06, 2009. Female patient, weighting 94.80 lb, was diagnosed with breast cancer

, gastric ulcer and was treated with Femara. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, blood lactate dehydrogenase increased, c-reactive protein increased, cardiac failure, cardiomegaly, dyspnoea, dyspnoea exertional, gamma-glutamyltransferase increased, gingival bleeding. Femara dosage: 2.5 MG, QD. During the same period patient was treated with ZOMETA, TAKEPRON, MUCOSTA, STRONTIUM CHLORIDE SR, ADRIACIN, CYCLOPHOSPHAMIDE, PACLITAXEL. Patient recovered.

Femara Side Effects Report #6000312-4
Femara side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2008. Female patient, weighting 147.0 lb, was treated with Femara. After drug was administered, patient experienced the following side effects: abdominal pain upper, dry skin, dyspnoea, nausea

, occult blood positive, rectal haemorrhage, renal cyst, skin warm, urinary tract infection

. Femara dosage: 2.5 MG. Patient was hospitalized. Patient recovered.

Femara and dyspnoea

SideEffects101.com

Femara and dyspnoea Patient Reports February 10, 2012

side effects of Femara